Mangoceuticals subsidiary creates Series A Preferred Stock granting CEO 51% voting control

MANGOCEUTICALS, INC.

Series A Preferred Stock of M&P subsidiary gives holders 51% of total vote on all shareholder matters.
100 shares designated; expected to be issued to CEO Jacob Cohen under his employment agreement.
M&P cannot amend charter or issue more shares without 66-2/3% approval of Series A holders.
Designation filed Jan 9, 2025, effective same date; filed with Texas SOS on Jan 15.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MANGOCEUTICALS, INC.: Subsidiary M&P filed a Certificate of Designations establishing Series A Super Majority Voting Preferred Stock (effective 2025-01-09).

Change: charter amendment
Effective: 2025-01-09

Exact text from the filing

On January 9, 2025, Mango & Peaches Corp. (“ M&P ”), the current wholly-owned subsidiary of Mangoceuticals, Inc., a Texas corporation (the “ Company ”, “ we ” and “ us ”), filed a Certificate of Designations of Mango & Peaches Corp., establishing the designations, preferences, limitations, and relative rights of its Series A Super Majority Voting Preferred Stock (the “ Series A Preferred Stock ”), with the Secretary of State of Texas

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

MANGOCEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-25-002389

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.